Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma (clinicaltrials.gov) - Sep 3, 2026 - P1 | N=40 | Recruiting | Sponsor: Aspeya, Inc. | Trial completion date: Dec 2026 ➔ Mar 2027 | Trial primary completion date: Dec 2026 ➔ Mar 2027
Trial completion date • Trial primary completion date • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
|